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Abstract
Objective to assess the pattern of use of non-
steroidal anti-inflammatory drugs (nsaids) and propose 
methods whereby pharmacists can help to improve patient 
safety when these drugs are used.
Method a psychometrically-evaluated questionnaire 
was administered to 261 patients aged 18 and over 
who visited 13 different community pharmacies, 1 from 
each electoral district in malta and gozo, chosen by 
stratified random sampling. information about the socio-
demographic status, symptoms and disease states and the 
drugs taken in the past 6 months was collected. analysis of 
data was carried out using microsoft office Excel 2007 and 
the biomedical data package (bmdp) software.
Key findings results show a high prevalence of 
analgesic (>80% per district) and nsaid use (about 50% 
per district). the first drug of choice to relieve analgesia 
was paracetamol (67.1%) followed by diclofenac (37.2%). 
ibuprofen was the fourth drug of choice (7.3%). about 
65% of patients who took diclofenac stated that they 
self-prescribe the medication. statistical analysis of data 
showed an association between the use of nsaids, 
musculoskeletal pain and menstrual pain (both p=0.010). 
a number of patients at risk of gastro-intestinal bleeds, 
cardiovascular events and those suffering from asthma 
reported taking nsaids occasionally. the presence of risks 
of drug interactions was identified with various drugs.
Conclusion nsaids are overused in malta and 
are often administered indiscriminately. pharmacist 
intervention could ensure the rational and safe use of 
nsaids. this could be achieved by having a shared protocol 
between pharmacists and prescribers for appropriate 
prescribing and dispensing and by identifying scenarios 
where pharmacist prescribing can be carried out to ensure 
that the analgesic used is appropriate for the individual 
patient.  
Keywords nsaid use, patient safety, community 
pharmacists, physicians.
Introduction 
non-steroidal anti-inflammatory drugs (nsaids) are mostly 
used to relieve pain of musculoskeletal origin since they 
exhibit both analgesic and anti-inflammatory effect.1 
these drugs must be used with caution since they can 
cause serious adverse drug reactions that range from 
gastro-intestinal (gi) upsets and bleeding to cardiovascular 
events, damage to the kidneys and stroke.2,3,4,5 nsaids may 
interact with various other drugs including anticoagulants6, 
corticosteroids7 and selective serotonin reuptake inhibitors8 
where in all these cases the risk of gi bleeding increases. 
they also reduce the effect of antihypertensive drugs since 
they can cause fluid retention.9 patients on angiotensin-
converting enzyme inhibitors will be at a greater risk of 
kidney damage10 if they take nsaids concurrently. 
various nsaids are available in malta; however no national 
statistics exist on the actual quantities of different nsaids 
imported locally. no protocols on the use of nsaids in 
specific patients are established in primary care. 
the aims of this study were to assess the pattern of nsaid 
use in the community pharmacy setting, to identify gaps 
leading to improper use of these drugs and to propose 
measures to help improve patient safety in relation to 
nsaids administration. 
Method
the study was approved by the university research Ethics 
committee. an extensive literature review on the use and 
safety of nsaids was undertaken. a questionnaire was 
formulated, adapted from similar work done in italy in 
2004.11 the developed questionnaire was divided into 3 
parts; socio-demographic information, symptoms suffered 
from over the past 6 months and drugs taken over the past 
6 months, including corresponding information on these 
drugs, for example the route of administration, reasons 
for which the drugs in question were taken, interval and 
frequency of drug intake and the source of prescription. 
the questionnaire was validated and tested for reliability by 
statistical ‘Kappa testing’. the questionnaire was delivered 
in the form of an interview. an ‘inter-rater Kappa test’ was 
performed to ensure that no bias was introduced by the 
interviewer during the interview.
the setting involved 13 pharmacies, 1 from each electoral 
district in malta and gozo chosen by stratified random, 
sampling. one afternoon was spent in each pharmacy 
to carry out the interviews. subjects were recruited 
on a voluntary basis and with their informed consent.
the collection of data was confidential and anonymous. 
analysis of data was carried out using microsoft office Excel 
2007 and the biomedical data package (bmdp). safe use of 
nsaids were identified from the reviewed literature.1,2,12,13
16
Results
a total of 261 questionnaires were collected. seventy one 
percent (n=186) of the respondents were female. the 
average age was 48 years and the range was 18-79 years. 
both Kappa tests performed gave values of over 0.75 
indicating reliability of the questionnaire.
results show that during the study period, more than 80% 
(n=241) of patients per district had used analgesics for the 
past 6 months and about 50% (n=131) of these patients had 
been using nsaids (figure 1). 
about 78% of the nsaid users reported taking the drugs for 
over 6 months, 55% of these stated that they take the drugs 
Figure 1: frequency of different analgesics used by patients by district over the past six months (n=261)
every now and then and 65% stated that when they do take 
nsaids they take them only for a day or two.
looking at the prevalence of nsaid use it was found that 
9% more females than males make use of nsaids. it was 
established that 11% more of the younger generation 
administer nsaids when compared to the elderly. both 
these facts were also reported in the italian survey.11
when ranking analgesic use (figure 2)  it was found that the 
first drug of choice as an analgesic was paracetamol with a 
frequency of 67% (n=175), followed by diclofenac with 37% 
(n=97). 
Figure 2: ranking list of analgesics used in the study (n=261)
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ibuprofen was the fourth commonly used drug with 7% 
(n=19), aspirin was the tenth commonly used drug with 1% 
(n=3) and naproxen ranked in the fourteenth place with 
0.4% (n=1). about 65% (n=63) of patients taking diclofenac 
admitted to self-prescribe the drug (figure 3). 
a statistical significant association was found between 
the use of nsaids and musculo-skeletal pain and the use 
of nsaids and menstrual pain (both p=0.010). patients 
reported using nsaids mainly to treat back pain, sciatica, 
joint pain and menstrual pain.
results show that 52% (n=34) of the patients suffering 
from gi symptoms, 47% (n=50) of the patients suffering 
from cardiovascular disorders, 35% (n=8) of the patients 
exhibiting respiratory disturbances and 43% (9) of those 
with diabetes reported taking nsaids. risk of drug 
interactions was encountered in patients taking: anti-
thrombotics (50%, n=12), the anti-hypertensive drugs 
including beta blockers, calcium channel blockers 
and alpha-adrenergic blockers (45%, n=17), diuretics 
(44%, n=14), angiotensin converting enzyme inhibitors 
(38%, n=19) and neuroleptics (50%, n=10). 
Discussion  
this study shows that the overall use of nsaids in malta 
(50.2%) is nearly double the usage reported in the italian 
study (23.1%). chronic nsaid use, that is daily use of nsaids 
for 4 weeks or more, is similar in italy (4.2%) and in malta 
(5%). locally, nsaids are being used frequently but for short 
periods of time. 
in other studies ibuprofen and aspirin are the most commonly 
used nsaids.11,14,15 the difference could be attributed to the 
lack of protocols for nsaid use in malta. naproxen, which 
according to the british national formulary (bnf)1 is “one 
of the first choices as an nsaid because it combines good 
efficacy with a low incidence of side-effects” has shown 
very low frequency of use. most patients self-prescribe the 
drugs and this indicates the need for framework where 
pharmacists can undertake prescribing activity so as to 
guide patients to more rationale options of therapy.
the study indicates that the female population administer 
more nsaids compared to males. reasons for this could 
be since females are more prone to conditions for which 
nsaids are indicated such as osteoarthritis, rheumatoid 
arthritis, dysmenorrhea and menorrhagia.
nsaid use among the younger generation was higher 
compared to the elderly. one reason for this could be that 
young people resort immediately to medication that relieves 
pain fast. moreover, they may have a lower tolerance to pain. 
the responsibility of a pharmacist in such circumstances is 
to recommend non-pharmacological treatment to control 
pain before resorting to any medications and to remind 
them that whenever they do self-administer a medicine 
they should first read the patient information leaflet. 
Figure 3: source of diclofenac prescription and advice (n=97)
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this study has shown that the maltese public are using 
nsaids for their appropriate indications. yet, there is a high 
prevalence of nsaid use by patients whose co-morbidities 
entail caution in the administration of this drug class. various 
possibilities of drug interactions were identified indicating 
that patients need to be better advised about the use of 
their medication by physicians and pharmacists. 
to enhance patient safety with regards to nsaid 
administration, this study proposes the use of a protocol 
based on a protocol developed by the canadian 
association of gastroenterology.9 this protocol includes 
recommendations about the use of different nsaids 
depending on the presence or absence of gi and 
cardiovascular risk factors (figure 4). 
the introduction of a pharmacist prescribing scheme, 
which could be initiated within a supplementary prescriber 
model, is suggested wherein doctors and pharmacists work 
in voluntary partnership to ensure that medicines are being 
administered properly and safely to all patients.16 
Figure 4: protocol for nsaid use (adapted from the canadian association of gastroenterology: rostom et al, 2009)
Conclusion
this study has shown that although nsaids are used 
for a short timeframe, they are still being overused by 
the maltese general population. more advice is required 
regarding rationale use, cautions and interactions. to rectify 
such a situation this study is proposing the introduction of 
a protocol for the dispensing and prescribing of this class 
of drugs and the possibility of introducing a pharmacist 
prescribing scheme where physicians and pharmacists 
work in collaboration to ensure optimisation of the risk/
benefit ratio of these drugs in each individual patient. 
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